Eric Collisson

Eric Collisson is a Professor of Human Biology and the Director of Translational Oncology at Fred Hutch, a position held since January 2024. Collisson is also a Co-Founder of Tatara Therapeutics since January 2019. Previously, a Professor and Medical Oncologist at the University of California, San Francisco from August 2005 to February 2024, Collisson completed medical training as an intern and resident at Stanford University Medical Center from 2003 to 2005. Collisson holds an MD in Medicine from UCLA, obtained between 1997 and 2002, and a BA in Molecular Biology from the University of California, Berkeley, earned from 1992 to 1996.